Impact of Total Coronary Revascularization Via Left Anterior Thoracotomy (TCRAT) vs. Robotic-Assisted Harvesting of LIMA (ITcrats)
Launched by MOHAMED R EL TAHAN · May 16, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to perform a heart surgery called total coronary revascularization. The goal is to see if one method, which uses robotic assistance, is better than the other method that does not use robots. Researchers want to find out which method leads to shorter hospital stays, lower healthcare costs, and is safer for patients. If both methods are found to be equally effective and safe, the non-robotic method may be preferred because it is easier to perform.
To be eligible for this trial, participants should be scheduled for elective heart surgery that requires the use of a heart-lung machine and will be under general anesthesia. However, certain patients cannot participate, such as those who are pregnant, require emergency surgery, or have specific health issues like severe heart failure. If you join the trial, you can expect close monitoring during your surgery and recovery, and you’ll be contributing to important research that could help improve heart surgery techniques in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled for any type of elective minimally invasive coronary revascularization surgery.
- • Using CPB.
- • General anesthesia is provided in an endotracheally intubated patient
- Exclusion Criteria:
- • Planned for coronary revascularization surgery without CPB;
- • Planned for a combined coronary revascularization surgery and a valve or intra-cardiac surgery;
- • LVEF less than 35%;
- • Preoperative cardiogenic shock;
- • Pregnancy;
- • Scheduled for re-do or emergency surgery;
- • Consent for another interventional study during anesthesia;
- • No written informed consent;
- • Preoperative need for mechanical circulatory support;
- • Preoperative need for invasive ventilatory support;
About Mohamed R El Tahan
Mohamed R. El Tahan is a distinguished clinical trial sponsor with a focus on advancing medical research and innovation. With a commitment to improving patient outcomes, he leads initiatives that prioritize rigorous scientific methodologies and ethical standards in clinical trials. His expertise spans various therapeutic areas, fostering collaborations with healthcare professionals and institutions to ensure comprehensive study designs and robust data analysis. Under his guidance, clinical trials are conducted with a strong emphasis on patient safety and regulatory compliance, contributing to the development of effective therapies and enhancing the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dammam, Eastern, Saudi Arabia,, Saudi Arabia
Dammam, , Saudi Arabia
Patients applied
Trial Officials
Mohamed R El Tahan, MD
Study Chair
Consultant in Cardiac Anesthesia
Fahad Makhdoum, MD
Principal Investigator
Assistant Professor, Cardiac Surgery
Yasser F ElGhoneimy, MD
Study Director
Professor, Cardiac Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported